ATE321561T1 - Azidoderivate von beta-l-2'-nukleosiden zur hiv- infektionsbehandlung - Google Patents

Azidoderivate von beta-l-2'-nukleosiden zur hiv- infektionsbehandlung

Info

Publication number
ATE321561T1
ATE321561T1 AT99971324T AT99971324T ATE321561T1 AT E321561 T1 ATE321561 T1 AT E321561T1 AT 99971324 T AT99971324 T AT 99971324T AT 99971324 T AT99971324 T AT 99971324T AT E321561 T1 ATE321561 T1 AT E321561T1
Authority
AT
Austria
Prior art keywords
beta
acido
nucleosides
derivatives
hiv infection
Prior art date
Application number
AT99971324T
Other languages
English (en)
Inventor
Gilles Gosselin
Jean-Louis Imbach
Jean-Pierre Sommadossi
Raymond F Schinazi
Original Assignee
Centre Nat Rech Scient
Uab Research Foundation
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Uab Research Foundation, Univ Emory filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE321561T1 publication Critical patent/ATE321561T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99971324T 1998-11-05 1999-11-05 Azidoderivate von beta-l-2'-nukleosiden zur hiv- infektionsbehandlung ATE321561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10717898P 1998-11-05 1998-11-05
US11586299P 1999-01-13 1999-01-13

Publications (1)

Publication Number Publication Date
ATE321561T1 true ATE321561T1 (de) 2006-04-15

Family

ID=26804484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971324T ATE321561T1 (de) 1998-11-05 1999-11-05 Azidoderivate von beta-l-2'-nukleosiden zur hiv- infektionsbehandlung

Country Status (12)

Country Link
EP (1) EP1124565B1 (de)
JP (2) JP2002528510A (de)
KR (1) KR100679239B1 (de)
AT (1) ATE321561T1 (de)
AU (1) AU768059B2 (de)
BR (1) BR9915037A (de)
CA (1) CA2348948C (de)
DE (1) DE69930678T2 (de)
ES (1) ES2262366T3 (de)
IL (2) IL142982A0 (de)
MX (1) MXPA01004505A (de)
WO (1) WO2000025799A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CA2410579C (en) 2000-05-26 2010-04-20 Jean-Pierre Sommadossi Methods and compositions for treating flaviviruses and pestiviruses
CN1849142A (zh) 2002-11-15 2006-10-18 埃迪尼克斯(开曼)有限公司 2′-支链核苷和黄病毒突变

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
WO1995007086A1 (en) * 1993-09-10 1995-03-16 Emory University Nucleosides with anti-hepatitis b virus activity
DE69638137D1 (de) * 1995-09-07 2010-04-15 Univ Georgia Therapeutische azidverbindungen
JP2002503212A (ja) * 1996-10-16 2002-01-29 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド 単環式ヌクレオシド、その類似体および使用

Also Published As

Publication number Publication date
AU1469100A (en) 2000-05-22
JP2002528510A (ja) 2002-09-03
IL142982A (en) 2010-05-17
IL142982A0 (en) 2002-04-21
CA2348948C (en) 2007-09-18
KR20020013475A (ko) 2002-02-20
BR9915037A (pt) 2001-11-20
DE69930678D1 (de) 2006-05-18
JP2011251968A (ja) 2011-12-15
EP1124565B1 (de) 2006-03-29
EP1124565A1 (de) 2001-08-22
AU768059B2 (en) 2003-12-04
CA2348948A1 (en) 2000-05-11
MXPA01004505A (es) 2005-04-19
WO2000025799A1 (en) 2000-05-11
ES2262366T3 (es) 2006-11-16
DE69930678T2 (de) 2006-09-21
KR100679239B1 (ko) 2007-02-07

Similar Documents

Publication Publication Date Title
DK1104436T3 (da) Beta-L-2'-deoxy-nukleosider til behandling af hepatitis B-virus
ATE315574T1 (de) Nukleoside mit anti-hepatitis b virus wirkung
PA8483101A1 (es) Compuestos quimicos
RU95110698A (ru) Способ лечения инфекций, вызываемых вирусом гепатита в
BR0110023A (pt) Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
PT790974E (pt) Acidos 4-biarilbutiricos ou 5-biarilpentanoicos substituidos e seus derivados como inibidores de metaloproteinas de matriz
DE10399025I2 (de) Wirkstoffvorläufer von Phosphonaten
DK1165096T3 (da) Anvendelse af cytidinderivater til behandling af leukæmi
ATE321561T1 (de) Azidoderivate von beta-l-2'-nukleosiden zur hiv- infektionsbehandlung
DK462688D0 (da) Anvendelse af nukleosider til fremstilling af laegemiddel til behandling af sygdomme foraarsaget af retrovirus eller hepatitis b virus
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
DE69019404T2 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
RU2001115094A (ru) Нуклеозиды, обладающие активностью против вируса гепатита в
NO905521D0 (no) 2-formylbenzylfosfonsyre-derivater, deres fremstilling oganvendelse til behandling av sykdommer som er foraarsaket av virus.
CA2538205A1 (en) Nucleosides with anti-hepatitis b virus activity
KR940000471A (ko) D-만노피라노스 화합물과 그의 제조방법
MX9706942A (es) Compuestos quimicos.
RU96117323A (ru) L-нуклеозиды для лечения заболеваний, вызванных вирусом гепатита b и вирусом эпштейна - барра
BG103727A (en) Hiv protease inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties